Gene therapy and stem cell transplantation show promise in age-related macular degeneration
Автор: NewYork-Presbyterian Hospital
Загружено: 2025-09-26
Просмотров: 1244
Описание: Dr. Tongalp Tezel, M.D., director of vitreoretinal services at NewYork-Presbyterian and Columbia, discusses current research on novel treatment alternatives to the current standard of care for age-related macular degeneration (AMD). Active clinical trials include gene therapy, which uses a surgically implanted adeno-associated virus to enable production of anti-VEGF agents in the eye, and stem cell transplantation to replenish retinal pigment epithelial cells. Early results from these trials are promising, with the potential to slow disease progression and restore vision loss.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: